Ashwin Kishtagari, MBBS, is Assistant Professor of Medicine in the division of hematology and oncology at Vanderbilt ...

CPX-351 improved overall survival among older patients with myelodysplastic-related AML who undergo hematopoietic transplantation. CPX-351 treatment resulted in improved overall survival (OS) among ...

Acute myeloid leukemia (AML) is a type of cancer that begins in the blood-forming cells of the bone marrow. Doctors do not stage AML like many other cancers, as it does not typically form tumors.

A new research paper titled "MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway" has been published in Oncotarget. Acute myeloid leukemia ...

Foghorn Therapeutics Inc. FHTX recently announced that the FDA has placed a full clinical hold on the phase I dose escalation study of pipeline candidate FHD-286 in relapsed and/or refractory acute ...

Chemotherapy, the main treatment for acute myeloid leukemia (AML), may cause unpleasant side effects. For this reason, some people with AML research natural treatments. AML is one of the most ...

Treatment of older patients with AML involves complex decisions taking into consideration age, fitness, treatment tolerability, quality of life, and social support. Increased treatment options have ...